Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by precipitous decline in sequencing costs and subsequent genomic data, ascendancy of precision medicine and personalized healthcare, and intensifying investment and innovation in AI for drug discovery.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The AI in genomics market is segmented as below:
By Component
- Software
- Hardware
- Services
By Technology
- Machine learning
- Computer vision
By End-user
- Pharmaceutical and biotech companies
- Research centers
- Healthcare providers
- Others
By Geographical Landscape
- North America
- Europe
- APAC
- Middle East and Africa
- South America
The report on the AI in genomics market covers the following areas:
- AI In Genomics Market sizing
- AI In Genomics Market forecast
- AI In Genomics Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global ai in genomics market: BenevolentAI, Data4Cure Inc., Deep Genomics Inc., DNAnexus Inc., Engine Biosciences Pte.Ltd., Fabric Genomics Inc., FDNA Inc., Freenome Holdings Inc., Genoox, International Business Machines Corp., Invitae Corp., Lifebit Biotech Inc, Microsoft Corp., MolecularMatch Inc., NVIDIA Corp., PrecisionLife Ltd, SOPHiA GENETICS, and Verge Analytics Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is proliferation of generative ai and foundation models in biology."
According to the report, one of the major drivers for this market is the precipitous decline in sequencing costs and subsequent genomic data.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BenevolentAI
- Data4Cure Inc.
- Deep Genomics Inc.
- DNAnexus Inc.
- Engine Biosciences Pte.Ltd.
- Fabric Genomics Inc.
- FDNA Inc.
- Freenome Holdings Inc.
- Genoox
- International Business Machines Corp.
- Invitae Corp.
- Lifebit Biotech Inc
- Microsoft Corp.
- MolecularMatch Inc.
- NVIDIA Corp.
- PrecisionLife Ltd
- SOPHiA GENETICS
- Verge Analytics Inc.

